TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 60 filers reported holding TYRA BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,724,223 | -19.1% | 2,739,595 | 0.0% | 1.02% | -21.8% |
| Q2 2023 | $46,655,303 | -10.4% | 2,739,595 | -15.4% | 1.30% | -31.7% |
| Q1 2023 | $52,060,292 | +177.1% | 3,239,595 | +31.0% | 1.90% | +140.0% |
| Q4 2022 | $18,789,685 | -13.5% | 2,472,327 | 0.0% | 0.79% | -11.7% |
| Q3 2022 | $21,732,000 | +22.9% | 2,472,327 | 0.0% | 0.90% | +5.2% |
| Q2 2022 | $17,677,000 | -33.2% | 2,472,327 | 0.0% | 0.85% | -19.3% |
| Q1 2022 | $26,454,000 | +0.4% | 2,472,327 | +32.0% | 1.06% | +10.6% |
| Q4 2021 | $26,358,000 | -11.6% | 1,873,332 | +10.5% | 0.96% | -17.7% |
| Q3 2021 | $29,814,000 | – | 1,694,933 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $60,725,576 | 53.26% |
| Nextech Invest Ltd. | 2,518,582 | $34,680,874 | 10.51% |
| Boxer Capital, LLC | 6,448,359 | $88,793,903 | 4.73% |
| TCG Crossover Management, LLC | 1,989,103 | $27,389,948 | 4.03% |
| Fairmount Funds Management LLC | 1,393,329 | $19,186,140 | 2.31% |
| RA Capital Management | 7,236,454 | $99,645,972 | 1.96% |
| 5AM Venture Management, LLC | 411,450 | $5,665,667 | 1.63% |
| BVF INC/IL | 2,739,595 | $37,724,223 | 1.02% |
| Frazier Life Sciences Management, L.P. | 1,028,013 | $14,155,739 | 0.94% |
| Auour Investments LLC | 85,020 | $1,198,782 | 0.51% |